JP2023145596A5 - - Google Patents

Download PDF

Info

Publication number
JP2023145596A5
JP2023145596A5 JP2023121307A JP2023121307A JP2023145596A5 JP 2023145596 A5 JP2023145596 A5 JP 2023145596A5 JP 2023121307 A JP2023121307 A JP 2023121307A JP 2023121307 A JP2023121307 A JP 2023121307A JP 2023145596 A5 JP2023145596 A5 JP 2023145596A5
Authority
JP
Japan
Prior art keywords
oil
animal
vaccine
vaccine according
based adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023121307A
Other languages
English (en)
Japanese (ja)
Other versions
JP7696960B2 (ja
JP2023145596A (ja
Filing date
Publication date
Priority claimed from PCT/EP2018/083297 external-priority patent/WO2019110481A1/en
Application filed filed Critical
Publication of JP2023145596A publication Critical patent/JP2023145596A/ja
Publication of JP2023145596A5 publication Critical patent/JP2023145596A5/ja
Application granted granted Critical
Publication of JP7696960B2 publication Critical patent/JP7696960B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023121307A 2017-12-04 2023-07-26 レプリコン粒子および油性アジュバントによるワクチン接種 Active JP7696960B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762594342P 2017-12-04 2017-12-04
US62/594,342 2017-12-04
US201762607101P 2017-12-18 2017-12-18
US62/607,101 2017-12-18
PCT/EP2018/083297 WO2019110481A1 (en) 2017-12-04 2018-12-03 Vaccination with replicon particles and oil adjuvant
JP2020530342A JP7354106B2 (ja) 2017-12-04 2018-12-03 レプリコン粒子および油性アジュバントによるワクチン接種

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020530342A Division JP7354106B2 (ja) 2017-12-04 2018-12-03 レプリコン粒子および油性アジュバントによるワクチン接種

Publications (3)

Publication Number Publication Date
JP2023145596A JP2023145596A (ja) 2023-10-11
JP2023145596A5 true JP2023145596A5 (https=) 2023-11-15
JP7696960B2 JP7696960B2 (ja) 2025-06-23

Family

ID=64661329

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020530342A Active JP7354106B2 (ja) 2017-12-04 2018-12-03 レプリコン粒子および油性アジュバントによるワクチン接種
JP2023121307A Active JP7696960B2 (ja) 2017-12-04 2023-07-26 レプリコン粒子および油性アジュバントによるワクチン接種

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020530342A Active JP7354106B2 (ja) 2017-12-04 2018-12-03 レプリコン粒子および油性アジュバントによるワクチン接種

Country Status (9)

Country Link
US (2) US12239702B2 (https=)
EP (1) EP3720488A1 (https=)
JP (2) JP7354106B2 (https=)
KR (2) KR20250116783A (https=)
CN (2) CN120771270A (https=)
BR (1) BR112020011044A2 (https=)
CA (1) CA3084042A1 (https=)
MX (2) MX2020005584A (https=)
WO (1) WO2019110481A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3720489A1 (en) * 2017-12-04 2020-10-14 Intervet International B.V. Canine lyme disease vaccine
EP4168429A1 (en) * 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
BR112022025678A2 (pt) * 2020-06-19 2023-01-17 Intervet Int Bv Vacina contra o vírus da influenza a suína compreendendo duas partículas de replicon de rna distintas
BR112023004123A2 (pt) 2020-09-07 2023-04-04 Intervet Int Bv Vacina de haste da ha para alvos positivos de anticorpos de ha
AR124849A1 (es) 2021-02-11 2023-05-10 Intervet Int Bv Vacuna para mycoplasma bovis
MX2024000544A (es) 2021-07-13 2024-04-09 Intervet Int Bv Superacion de la interferencia de los anticuerpos en las aves.
US20250281597A1 (en) 2021-10-25 2025-09-11 Intervet Inc. A vaccine for the protection of piglets against swine influenza a virus infection

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
JPH11269093A (ja) 1998-01-22 1999-10-05 Shionogi & Co Ltd 油性アジュバントワクチン製剤
NZ527322A (en) 2001-01-04 2005-07-29 Univ Saskatchewan EHEC cell culture supernatant vaccine
KR20060017635A (ko) 2003-06-05 2006-02-24 와이어쓰 홀딩스 코포레이션 베네쥬엘라 말 뇌염 바이러스 레플리콘 벡터 및파라믹소바이러스 단백질 항원을 포함하는 면역원성 조성물
DE602004021260D1 (de) 2003-07-11 2009-07-09 Alphavax Inc Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
CN1989250B (zh) 2004-05-18 2013-11-20 阿尔法瓦克斯公司 Tc-83衍生的甲病毒属载体、颗粒和方法
US7805252B2 (en) 2005-08-16 2010-09-28 Dna Twopointo, Inc. Systems and methods for designing and ordering polynucleotides
US8460913B2 (en) 2007-06-21 2013-06-11 Alpha Vax, Inc. Promoterless cassettes for expression of alpha virus structural proteins
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌(Lawsonia intracellularis)用疫苗
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗
US7561972B1 (en) 2008-06-06 2009-07-14 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
US7561973B1 (en) 2008-07-31 2009-07-14 Dna Twopointo, Inc. Methods for determining properties that affect an expression property value of polynucleotides in an expression system
US8126653B2 (en) 2008-07-31 2012-02-28 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
AU2009287449B2 (en) 2008-08-29 2015-04-30 Boehringer Ingelheim Animal Health USA Inc. West nile virus vaccine
US8425922B2 (en) * 2009-01-05 2013-04-23 EpitoGenesis, Inc. Adjuvant compositions and methods of use
RU2580299C2 (ru) 2009-06-29 2016-04-10 Дженосеа Биосайенсиз, Инк. Вакцины и композиции, направленные против streptococcus pneumoniae
CA2766907A1 (en) * 2009-07-06 2011-01-13 Novartis Ag Self replicating rna molecules and uses thereof
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
NZ606591A (en) 2010-07-06 2015-02-27 Novartis Ag Cationic oil-in-water emulsions
HUE028877T2 (en) 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
EP2471926A3 (en) 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
BR112013023354B1 (pt) 2011-03-14 2022-02-15 Boehringer Ingelheim Animal Health Usa Inc Composição imunogênica compreendendo cepas de vírus da rinite equina a (erav) e seu método de produção
PL2714908T3 (pl) 2011-05-26 2018-07-31 Intervet International B.V. Oligodeoksynukleotydy immunostymulacyjne
MX346596B (es) 2011-05-26 2017-03-23 Intervet Int Bv Oligodesoxinucleotidos inmunoestimuladores.
JP6059220B2 (ja) * 2011-07-06 2017-01-18 ノバルティス アーゲー 核酸を含む水中油型エマルジョン
UA115053C2 (uk) 2012-03-07 2017-09-11 Сева Санте Анімаль Композиція, що містить антиген і ліпополісахарид у формі масло-в-воді, та спосіб її використання (варіанти)
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US20150140068A1 (en) * 2012-07-06 2015-05-21 Novartis Ag Immunogenic compositions and uses thereof
EP3076997B1 (en) * 2013-12-03 2018-08-29 Intervet International B.V. Swine vaccine against prrs and lawsonia intracellularis
EP3191125B1 (en) 2014-09-12 2024-11-20 Intervet International B.V. Vaccine for use in protecting offspring of a sow against porcine endemic diarrhea virus
CN108697782A (zh) * 2016-03-23 2018-10-23 英特维特国际股份有限公司 针对pcv2病毒和猪肺炎支原体感染的组合疫苗
EP3558351B1 (en) 2016-12-23 2022-01-26 Intervet International B.V. Combination vaccine for swine

Similar Documents

Publication Publication Date Title
JP2023145596A5 (https=)
Anderson Immunostimulants, adjuvants, and vaccine carriers in fish: applications to aquaculture
Sabaté et al. A single-centre, open-label, controlled, randomized clinical trial to assess the preventive efficacy of a domperidone-based treatment programme against clinical canine leishmaniasis in a high prevalence area
Gudding et al. The history of fish vaccination
Gomis et al. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs
RU2434638C2 (ru) Вакцина альфа токсоида с.perfringens
Munang’andu et al. An overview of challenges limiting the design of protective mucosal vaccines for finfish
Evensen Development of fish vaccines: Focusing on methods
Sharifuzzaman et al. Subcellular components of probiotics Kocuria SM1 and Rhodococcus SM2 induce protective immunity in rainbow trout (Oncorhynchus mykiss, Walbaum) against Vibrio anguillarum
Gerdts Adjuvants for veterinary vaccines--types and modes of action
Bedekar et al. Fundamentals of fish vaccination
BR0007936A (pt) Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno
Patil et al. Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies
Siwicki et al. Influence of immunostimulants on the effectiveness of vaccines in fish: in vitro and in vivo study
JP2025500351A5 (https=)
Tayade et al. L-Arginine stimulates intestinal intraepithelial lymphocyte functions and immune response in chickens orally immunized with live intermediate plus strain of infectious bursal disease vaccine
Kole et al. Potential efficacy of chitosan-poly (Lactide-Co-glycolide)-encapsulated trivalent immersion vaccine in olive flounder (Paralichthys olivaceus) against viral hemorrhagic septicemia virus, Streptococcus parauberis serotype I, and Miamiensis avidus (Scuticociliate)
Okpe et al. Vitamin A dietary supplementation reduces the mortality of velogenic Newcastle disease significantly in cockerels
CA2931139C (en) Swine vaccine against prrs and lawsonia intracellularis
Yu et al. The immune enhancement effect of CpG-ODNs on the vaccine of inactivated Vibrio harveyi in tiger puffer (Takifugu rubripes)
JP5865350B2 (ja) 母系由来の抗体の存在下での投与に適したマイコプラズマ・ハイオニュ−モニエに対するワクチン
WO2000037045B1 (en) Stabilized water-in-oil-in-water antigen delivery system
Abdy et al. Comparative effect of Freund's adjuvant and Aloe vera L. gel on the expression of TNF‐α and IL‐1β in vaccinated Cyprinus carpio L. with Aeromonas hydrophila C. bacterin
Thuy et al. Specific humoral immune response and protection against Vibrio parahaemolyticus in orange-spotted grouper Epinephelus coioides
JP6077541B2 (ja) ワクチンのための分子アジュバントとしてのpacapの使用